Chemotherapy Plus Bevacizumab and Anti-PD-1 Followed by Induction Therapy of Chemotherapy Plus Bevacizumab

Clinical trial NCT06415851 · UNKNOWN

Trial details

NCT number: NCT06415851
Sponsor: Zhangfa Song
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Metastatic Colorectal Cancer MSS

Start date: 2024-06-01
Primary completion: 2025-05-30
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.